Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Hampig Raphael Kourie,1 Elie El Rassy,1 Florian Clatot,2,3 Evandro de Azambuja,4 Matteo Lambertini3,4 1Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon; 2Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France; 3Breast Cancer Transla...

Full description

Bibliographic Details
Main Authors: Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:OncoTargets and Therapy
Subjects:
Breast cancer
HER2-positive
neratinib
early-stage
targeted therapy.
Online Access:https://www.dovepress.com/emerging-treatments-for-her2-positive-early-stage-breast-cancer-focus--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/emerging-treatments-for-her2-positive-early-stage-breast-cancer-focus--peer-reviewed-article-OTT

Similar Items